After a holiday break, I'm back with another company.
Along with Prexton Therapeutics, another spin-off from the decline and fall of Merck Geneva
is Quartz Bio. This seems to be part of the big search for biomarkers in the field of stratified medicine. Stratified medicine (from my search of buzzwords) is one step above personalized medicine where you look at groups not individuals.
Quartz Bio is made from ex-Merck Geneva employees and seems to be made from those with experience in clinical bioinformatics. Their press release states that Merck Serono intends to use their services so that sounds like at least one potential client lined up.
They are going to be located near Geneva in Fongit, a tech incubator with connections to (among many other things) CTI.
No comments:
Post a Comment